Related references
Note: Only part of the references are listed.Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial
Paul B. Watkins et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety
Simona Lattanzi et al.
CNS DRUGS (2020)
The nephrologist's guide to cannabis and cannabinoids
Joshua L. Rein
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2020)
Abrupt withdrawal of cannabidiol (CBD): A randomized trial
Lesley Taylor et al.
EPILEPSY & BEHAVIOR (2020)
Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs
Dana Vaughn et al.
FRONTIERS IN VETERINARY SCIENCE (2020)
A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report
Juliana Andrea Ponton et al.
JOURNAL OF MEDICAL CASE REPORTS (2020)
Medical Cannabis in Children
Adi Aran et al.
RAMBAM MAIMONIDES MEDICAL JOURNAL (2020)
Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study
Elizabeth Thiele et al.
EPILEPSIA (2019)
Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy
Debopam Samanta
PEDIATRIC NEUROLOGY (2019)
Cannabidiol as a suggested candidate for treatment of autism spectrum disorder
Shani Poleg et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Current state of evidence of cannabis utilization for treatment of autism spectrum disorders
Rumi Agarwal et al.
BMC PSYCHIATRY (2019)
Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US
Tristan T. Sands et al.
CNS DRUGS (2019)
Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities
Dana Barchel et al.
FRONTIERS IN PHARMACOLOGY (2019)
Polyunsaturated fatty acids and endocannabinoids in health and disease
Hercules Rezende Freitas et al.
NUTRITIONAL NEUROSCIENCE (2018)
The pharmacokinetics and the pharmacodynamics of cannabinoids
Catherine J. Lucas et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders
Stephanie Libzon et al.
JOURNAL OF CHILD NEUROLOGY (2018)
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
Simona Lattanzi et al.
DRUGS (2018)
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
Sophie A. Millar et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models
Erica Zamberletti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Marijuana Use in Epilepsy: The Myth and the Reality
Kamil Detyniecki et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2015)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Orrin Devinsky et al.
EPILEPSIA (2014)
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1aΔE9 mice
David Cheng et al.
PSYCHOPHARMACOLOGY (2014)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Ethan B. Russo
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Share Paper
